Caris Life Sciences (CAI) Cash & Current Investments (2024 - 2026)

Caris Life Sciences' Cash & Current Investments history runs 3 years deep, the most recent figure standing at $823.5 million for Q1 2026.

• In Q1 2026, Cash & Current Investments changed N/A year-over-year to $823.5 million; the TTM figure through Mar 2026 stood at $823.5 million (changed N/A YoY), while the FY2025 annual figure was $800.1 million, up 1082.82% from the prior year.
• Cash & Current Investments for Q1 2026 stood at $823.5 million, up from $800.1 million in the prior quarter.
• The five-year high for Cash & Current Investments was $823.5 million in Q1 2026, with the low at $67.6 million in Q4 2024.
• The 3-year median for Cash & Current Investments is $757.0 million (2025), against an average of $634.0 million.
• Peak annual rise in Cash & Current Investments reached 1082.82% in 2025, while the deepest fall reached 1082.82% in 2025.
• Caris Life Sciences' Cash & Current Investments stood at $67.6 million in 2024, then soared by 1082.82% to $800.1 million in 2025, then increased by 2.92% to $823.5 million in 2026.
• Business Quant data shows CAI's Cash & Current Investments at $823.5 million in Q1 2026, $800.1 million in Q4 2025, and $757.0 million in Q3 2025.